Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03955211 · ClinicalTrials.gov registry record · Phase 2
HTX-011 Administration Study in Planned Caesarean Section Procedure
A Phase 2 study, sponsored by Heron Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT03955211: Completed Phase 2 study, sponsored by Heron Therapeutics.
NCT03955211 is a Phase 2 study that has completed, run by Heron Therapeutics. The registered enrollment target is 25 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03955211, a Phase 2 study, has completed, sponsored by Heron Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a Phase 2, open-label study to evaluate the PK and safety of HTX-011 in women undergoing a planned C-section.
Interventions
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG HTX-011
- DEVICE Luer Lock Applicator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-06-24 |
| Est. Completion | 2021-12-27 |
| Phase | Phase 2 |
What the finished NCT03955211 record still lists
NCT03955211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 4 interventions - of which Acetaminophen is the first listed.
NCT03955211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03955211 about?
NCT03955211 is a clinical study titled "HTX-011 Administration Study in Planned Caesarean Section Procedure". This is a Phase 2, open-label study to evaluate the PK and safety of HTX-011 in women undergoing a planned C-section.
What is the current status of trial NCT03955211?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2019-06-24. Estimated completion is 2021-12-27.
What interventions are being tested in trial NCT03955211?
The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), HTX-011 (DRUG), Luer Lock Applicator (DEVICE).
Who is sponsoring clinical trial NCT03955211?
This trial is sponsored by Heron Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03955211's enrollment target sits among peer trials
25 1719th of 2000 higher than 245 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI